Free Trial

Cytek Biosciences (CTKB) Insider Trading & Ownership

Cytek Biosciences logo
$6.13 0.00 (0.00%)
(As of 11/20/2024 ET)

Cytek Biosciences (NASDAQ:CTKB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$504,020.00
Get CTKB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cytek Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CTKB Insider Buying and Selling by Quarter

Cytek Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/19/2024Ming YanCTOSell20,000$5.87$117,400.00  
4/9/2024Ming YanCTOSell1,900$7.00$13,300.00  
3/18/2024Ming YanCTOSell20,000$6.77$135,400.00  
12/26/2023Patrik JeanmonodCFOSell3,000$9.50$28,500.00  
12/19/2023Ming YanCTOSell20,000$9.43$188,600.00  
11/24/2023Patrik JeanmonodCFOSell3,000$6.94$20,820.00  
11/20/2023Ming YanCTOSell20,000$6.03$120,600.00  
(Data available from 1/1/2013 forward)

CTKB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cytek Biosciences includes Jack Ball, Ming Yan, Patrik Jeanmonod, Ra Capital Management, L.P., and Wenbin Jiang. Learn more on insiders at CTKB.

9.60% of Cytek Biosciences stock is owned by insiders. Learn more on CTKB's insider holdings.

The following insiders have sold CTKB shares in the last 24 months: Ming Yan ($2,792,178.41), Patrik Jeanmonod ($331,360.00), and Wenbin Jiang ($2,170,400.00).

Insiders have sold a total of 601,389 Cytek Biosciences shares in the last 24 months for a total of $5,293,938.41 sold.

Cytek Biosciences Key Executives

  • Dr. Wenbin Jiang Ph.D. (Age 60)
    President, CEO & Chairman of the Board
    Compensation: $964.21k
  • Dr. Ming Yan Ph.D. (Age 61)
    CTO & Director
    Compensation: $616.26k
  • Ms. Valerie T. Barnett J.D. (Age 48)
    Chief Legal Officer
    Compensation: $535.98k
  • Mr. William D. McCombe (Age 66)
    Chief Financial Officer
  • Mr. Chris Williams (Age 55)
    Chief Operating Officer
  • Dr. Allen B. Poirson Ph.D. (Age 64)
    Senior Vice President of Business & Corporate Development
  • Dr. Philippe Busque Ph.D.
    Senior Vice President of Global Sales & Services
  • Mr. Patrik Sebastian Jeanmonod (Age 57)
    Head of Corporate Development Analytics
    Compensation: $412.54k


This page (NASDAQ:CTKB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners